Evidence map›Paper›PMID 21078904›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.

Lea Barfod, Tina Dobrilovic, Pamela Magistrado, Pongsak Khunrae, Firmine Viwami, Jonas Bruun, Madeleine Dahlbäck, Nadia L Bernasconi, Michal Fried, Davis John and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Production of PfEMP1-Specific Mouse Monoclonal Antibodies.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 11 countries.

Lea BarfodCentre for Medical Parasitology, Department of International Health, Immunology, and Microbiology, University of Copenhagen, Denmark.
Tina Dobrilovic
Pamela Magistrado
Pongsak Khunrae
Firmine Viwami
Jonas Bruun
Madeleine Dahlbäck
Nadia L Bernasconi
Michal Fried
Davis John
Patrick E Duffy
Ali Salanti
Antonio Lanzavecchia
Chwee Teck Lim
Nicaise Tuikue Ndam
Matthew K Higgins
Lars Hviid
University of Copenhagen · DKCenter for Infectious Disease Research · USInstitut de Recherche pour le Développement · BJInstitute for Biomedicine · ITBridge University · SSCambridge School · PTCopenhagen University Hospital · DKKeogh Institute for Medical Research · AUKilimanjaro Christian Medical Centre · TZNational University of Singapore · SGRigshospitalet · DK

Funding

Malaria Pathogenesis in young children and vaccine discoveryZIAAI001134 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DUFFY, PATRICK · 2010 to 2025
$11.3M
Intramural NIH HHS Z99 AI999999Intramural NIH HHS ZIA AI001134Wellcome Trust
6 · The paper itself

Abstract

Acquired protection from Plasmodium falciparum placental malaria, a major cause of maternal, fetal, and infant morbidity, is mediated by IgG specific for the P. falciparum erythrocyte membrane protein 1 variant VAR2CSA. This protein enables adhesion of P. falciparum-infected erythrocytes to chondroitin sulfate A in the intervillous space. Although interclonal variation of the var2csa gene is lower than that among var genes in general, VAR2CSA-specific Abs appear to target mainly polymorphic epitopes. This has raised doubts about the feasibility of VAR2CSA-based vaccines. We used eight human monoclonal IgG Abs from affinity-matured memory B cells of P. falciparum-exposed women to study interclonal variation and functional importance of Ab epitopes among placental and peripheral parasites from East and West Africa. Most placental P. falciparum isolates were labeled by several mAbs, whereas peripheral isolates from children were essentially nonreactive. The mAb reactivity of peripheral isolates from pregnant women indicated that some were placental, whereas others had alternative sequestration foci. Most of the mAbs were comparable in their reactivity with bound infected erythrocytes (IEs) and recombinant VAR2CSA and interfered with IE and/or VAR2CSA binding to chondroitin sulfate A. Pair-wise mAb combinations were more inhibitory than single mAbs, and all of the mAbs together was the most efficient combination. Each mAb could opsonize IEs for phagocytosis, and a combination of the eight mAbs caused phagocytosis similar to that of plasma IgG-opsonized IEs. We conclude that functionally important Ab epitopes are shared by the majority of polymorphic VAR2CSA variants, which supports the feasibility of VAR2CSA-based vaccines against placental malaria.

Indexed as

AdultAntibodies, MonoclonalAntibodies, ProtozoanB-LymphocytesChildChild, PreschoolChondroitin SulfatesEpitopesErythrocytesFemaleHumansMalaria, FalciparumMalaria VaccinesMalePlacentaPlasmodium falciparumAntibodies, MonoclonalAntibodies, ProtozoanChondroitin SulfatesEpitopeserythrocyte membrane protein 1, Plasmodium falciparumMalaria VaccinesProtozoan Proteins

Identifiers

PMID21078904
PMCPMC4785892
OpenAlexW1902770434

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.